DOI: 10.4244/EIJV8I8A136

Statement on matching language to the type of evidence used in describing outcomes data

The Editors of the HEART Group Journals*

There are many different types of studies that can be conducted to provide evidence for clinical and outcomes research including, but not limited to, retrospective observational analyses, case-control studies and randomised controlled trials (RCTs). Each of these analyses has strengths and limitations, but most importantly, they all result in different types of conclusions about an intervention.

As illustrated in a series of examples provided in a separate review1, inappropriate word choice to describe results can lead to scientific inaccuracy. Therefore, the editors of the HEART Group (representing the world’s cardiovascular journals) recommend that all investigators and editors carefully select language to “match” the type of study conducted, without overstating findings or drawing erroneous conclusions about causality when they cannot be established.

As an illustrative example, when reporting results from an observational study that shows fewer deaths in one arm than in another, one should use descriptive statements such as, “the intervention is associated with lower mortality,” rather than definitive statements such as, “the intervention reduces mortality.” Conversely, when reporting the results of a rigorously conducted RCT with complete follow-up, in which the only difference captured between the two groups was the intervention, it may be appropriate to use somewhat more declarative statements such as, “the intervention reduced risk.” Additional examples of language matched with corresponding study type are listed in the Table 1.

In conclusion, all manuscripts should be written and edited not only for scientific accuracy but also for appropriateness of language used in describing the level of evidence provided by the study.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 8 Number 8
Dec 28, 2012
Volume 8 Number 8
View full issue


Key metrics

Trending articles
95.95

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
76.55

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
63

Image – Interventional flashlight

10.4244/EIJ-D-22-00074 Jun 3, 2022
Transcatheter aortic valve repair for aortic regurgitation with the Cusper device
Feld Y et al
free
58.2

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
49.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
49.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
31.1

Expert Review

10.4244/EIJ-D-24-00535 May 5, 2025
Catheter-based techniques for pulmonary embolism treatment
Costa F et al
30.4

Clinical Research

10.4244/EIJ-D-21-00363 Jan 28, 2022
Membranous septum morphology and risk of conduction abnormalities after transcatheter aortic valve implantation
Jørgensen T et al
free
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved